Immunogenicity of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine compared to standard-dose diphtheria, tetanus, acellular pertussis when used as a pre-school booster in UK children: A 5-year follow-up of a randomised controlled study.

Dettagli Bibliografici
Autori principali:	John, T, Voysey, M, Yu, L, McCarthy, N, Baudin, M, Richard, P, Fiquet, A, Kitchin, N, Pollard, A
Natura:	Journal article
Lingua:	English
Pubblicazione:	Elsevier 2015

Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.
di: Collins, C, et al.
Pubblicazione: (2004)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
di: Bahaa Abu-Raya, et al.
Pubblicazione: (2019-10-01)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
di: Geert Leroux-Roels, et al.
Pubblicazione: (2018-01-01)

Investigating Tetanus, Diphtheria, Acellular Pertussis Vaccination During Pregnancy and Risk of Congenital Anomalies
di: Ana Florea, et al.
Pubblicazione: (2022-12-01)

Immunogenicity and safety of a low-dose diphtheria, tetanus and acelular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
di: Collins, C, et al.
Pubblicazione: (2004)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
di: Sidsel Skou Voss, et al.
Pubblicazione: (2020-11-01)

Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
di: Kyu Ri Kang, et al.
Pubblicazione: (2021-10-01)

Lichen planus following tetanus–diphtheria–acellular pertussis vaccination: A case report and review of the literature
di: Heather C Rosengard, et al.
Pubblicazione: (2018-01-01)

Desensitization with DTP (diphtheria, tetanus and pertussis) vaccine
di: Atanasković-Marković Marina, et al.
Pubblicazione: (2003-01-01)

Factors associated with receipt of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) in mothers who deliver preterm
di: Shetal I. Shah, et al.
Pubblicazione: (2023-03-01)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
di: Aapo Knuutila, et al.
Pubblicazione: (2023-12-01)

Mass Spectrometry-Based Quantification of the Antigens in Aluminum Hydroxide-Adjuvanted Diphtheria-Tetanus-Acellular-Pertussis Combination Vaccines
di: Larissa van der Maas, et al.
Pubblicazione: (2022-07-01)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
di: Peter Van den Steen, et al.
Pubblicazione: (2023-01-01)

Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage Among Publicly Insured Pregnant Women, U.S., 2016–2019
di: Cheryl J. Isenhour, DVM, et al.
Pubblicazione: (2023-03-01)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
di: Chukiat Sirivichayakul, et al.
Pubblicazione: (2017-01-01)

A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy
di: Raquel Quiles, et al.
Pubblicazione: (2023-08-01)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
di: Ammar Hussam
Pubblicazione: (2011-10-01)

Adverse Effects of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine in 6- to 7-Year-Old Children
di: Sung-Hsi Wei, et al.
Pubblicazione: (2011-02-01)

Comparative tetanus antibody response of Nigerian children to diphtheria-pertussis-tetanus and pentavalent vaccines
di: Helen Omini Uket, et al.
Pubblicazione: (2018-01-01)

A phase 2 study of a combined diphtheria-tetanus-acellular pertussis vaccine with a Sabin-derived inactivated poliovirus vaccine in children
di: Takashi Nakano, et al.
Pubblicazione: (2018-12-01)

Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
di: Hitt J Sharma, et al.
Pubblicazione: (2023-12-01)

Genetic Variation in the Magnitude and Longevity of the IgG Subclass Response to a Diphtheria-Tetanus-Acellular Pertussis (DTaP) Vaccine in Mice
di: Yung-Yi C. Mosley, et al.
Pubblicazione: (2019-09-01)

Impact of childhood and maternal vaccination against diphtheria, tetanus, and pertussis in Colombia
di: María Cristina Hoyos, et al.
Pubblicazione: (2021-11-01)

Commentary: Comparison of deaths after pentavalent vaccine and diphtheria-tetanus pertussis vaccine
di: S L Jadhav
Pubblicazione: (2018-01-01)

SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS
di: I. V. Feldblyum, et al.
Pubblicazione: (2016-02-01)

Serum sickness–like reaction after diphtheria, tetanus, acellular pertussis, inactivated polio and Haemophilus influenzae type b conjugate (5-in-1 vaccine) vaccination: A case report
di: Wei-Yu Chen, et al.
Pubblicazione: (2020-01-01)

Undervaccination with diphtheria, tetanus, and pertussis vaccine: National trends and association with pertussis risk in young children
di: Wan-Ting Huang, et al.
Pubblicazione: (2017-04-01)

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study
di: Asmik Asatryan, et al.
Pubblicazione: (2021-03-01)

Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort study
di: Melina Thibault, et al.
Pubblicazione: (2024-12-01)

Recommendation for use of diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine in infants
di: Hye-Kyung Cho, et al.
Pubblicazione: (2021-12-01)

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
di: Kuhyun Yang, et al.
Pubblicazione: (2022-12-01)

Guillain Barré syndrome after combined diphtheria, tetanus, and acellular pertussis (DTaP) vaccine: A rare pediatric case report and review of literature
di: Meichen Pan, et al.
Pubblicazione: (2023-08-01)

The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis
di: Bahaa Abu-Raya, et al.
Pubblicazione: (2021-07-01)

Assessing Geographic Overlap between Zero-Dose Diphtheria–Tetanus–Pertussis Vaccination Prevalence and Other Health Indicators
di: Emily Haeuser, et al.
Pubblicazione: (2023-04-01)

Immunogenicity and Reactogenicity of Diphtheria—Tetanus—Acellular Pertussis—Hepatitis B—Inactivated Poliovirus and Haemophilus influenzae Type B Vaccines Administered Concomitantly to Infants as a Three-dose Primary Course
di: Pei-Lan Shao, et al.
Pubblicazione: (2011-05-01)

Sex-differential non-vaccine specific immunological effects of diphtheria-tetanus-pertussis and measles vaccination
di: Noho-Konteh, F, et al.
Pubblicazione: (2016)

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines
di: Saliou Pierre, et al.
Pubblicazione: (2005-11-01)

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
Pubblicazione: (2020-03-01)

Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children
di: Soon Min Lee, et al.
Pubblicazione: (2019-05-01)

Documenti analoghi

Documenti analoghi